As another year draws to a close, policymakers, researchers, and partners are convening in South Africa to discuss typhoid, TCV, and the work that remains to combat this disease. Despite ...
Read more
Author: Venancious Tour, PATH
Typhoid takes a spotlight during the 2022 VASE Conference
VASE expands its scope Hundreds of scientists, public health professionals, immunization leaders, vaccine industry representatives, international donors, and other global experts gathered in Washington D.C. for the 2022 Vaccines Against ...
Read more
Test-negative design proves to be suitable for typhoid vaccine effectiveness evaluations
Background on test-negative design Typhoid continues to be a public health threat in sub-Saharan Africa. However, typhoid conjugate vaccine (TCV) is a proven intervention to reduce the burden of typhoid ...
Read more
Understanding the cost of typhoid in Malawi
Getting sick comes with costs—both physical as well as economic. Treatment costs and lost wages while recuperating or taking care of a sick family member can be detrimental to families. ...
Read more
Drug resistance: It takes a global village
Why drug resistance should be on our radar Drug resistance occurs when bacteria, viruses, fungi, and parasites change over time and no longer respond to treatment. As a result, medicines ...
Read more
In Kenya, advancing typhoid vaccine science and policy
Last month in Kericho, Kenya, our team was proud to launch a Phase 3 study of the EuTCV typhoid conjugate vaccine (TCV) candidate. As principal investigators based at Kenya Medical ...
Read more
Reaching every child in Pakistan: TCV rolls out to remaining provinces completing nationwide introduction
Today, Pakistan began their final typhoid conjugate vaccine (TCV) introduction campaign to ensure that children are protected against typhoid. This is a major achievement and fulfills a commitment from the ...
Read more
Unprecedented floods pose serious health risks in Pakistan
Environmental impacts on human health Droughts, floods, earthquakes—disasters our planet knows all too well. We have seen how these disasters have dramatic impacts on the health of communities. The recent ...
Read more
New TCV data from Malawi highlight longer-term immune response
Typhoid conjugate vaccine (TCV) is highly immunogenic in Malawian children as young as 9 months of age! New data show TCV elicits a strong immune response among both young children ...
Read more
A new diagnostic tool to understand typhoid burden
Typhoid remains extremely challenging to diagnose. The current gold standard diagnostic is laboratory confirmed blood culture. These tests are difficult to perform and require specialized laboratory skills and facilities. Many ...
Read more
